$1.42
At close: Jun 2 EDT
$1.34
-0.07-5.30%
Pre-Market: 5:50 PM EDT
Comments
Loading...
Akari Therapeutics (AKTX) Forecast
NewsEarningsAkari Therapeutics (AKTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Akari Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AKTX | Benzinga
Explore Akari Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AKTX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akari Therapeutics (AKTX) stock?
You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.
Who are Akari Therapeutics (AKTX) competitors?
Other companies in Akari Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Connect Biopharma Hldgs (NASDAQ:CNTB), Imunon (NASDAQ:IMNN), PepGen (NASDAQ:PEPG) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the forecast, or price target, for Akari Therapeutics (AKTX) stock?
Akari Therapeutics has a consensus price target of $2.75.
What is the current price for Akari Therapeutics (AKTX)?
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $1.34 last updated June 2, 2025 at 5:50 PM EDT.
Does Akari Therapeutics (AKTX) pay a dividend?
There are no upcoming dividends for Akari Therapeutics.
When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?
Akari Therapeutics’s Q2 earnings are confirmed for Monday, August 18, 2025.
Is Akari Therapeutics (AKTX) going to split?
There is no upcoming split for Akari Therapeutics.
What sector and industry does Akari Therapeutics (AKTX) operate in?
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
